This site uses cookies to store information on your computer. Learn more x

Pharma joint ventures

Leveraging partnerships for growth

DSM’s former Pharma Cluster comprises Patheon, formerly DPx Holdings, formed by combining DSM Pharmaceutical Products and Patheon Inc., a leading provider of CDMO services, pharmaceutical products and other formulated products for various industries, and DSM's joint venture interest in DSM Sinochem Pharmaceuticals, leader in beta-lactam anti-infectives.
DSM Sinochem Pharmaceuticals website

DSM Sinochem Pharmaceuticals

In August 2011 DSM and the Sinochem Group announced that DSM Sinochem Pharmaceuticals was operational. More>

Patheon website


In March 2014 DSM and JLL Partners (JLL), the middle-market private equity firm, announced that Patheon was operational. More>

Equity method

DSM reports on its investments in DSM Sinochem Pharmaceuticals and Patheon as associated accounts in accordance with the equity (50% & 49% respectively) method rather than as ongoing business. Consequently as of 1 January 2014 the (former) Pharma cluster is not included in DSM’s core EBITDA or activities.